CLEARSIDE BIOMEDICAL
1.1100
07-11月-24 14:59:58
15 分の遅延
株式
+0.0300
+2.78%
本日の幅
1.0800 - 1.1300
ISIN
N/A
ソース
NASDAQ
-
02 4 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Appoints Victor Chong, M.D., MBA as Chief Medical Officer
18 3 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
12 3 2024 15:05:00 提供 Nasdaq GlobeNewswire
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
12 3 2024 08:45:16 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
11 3 2024 11:16:48 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
08 3 2024 08:45:23 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
07 3 2024 08:45:03 提供 NetDania Notify
-
NetDania - New 12 months High: CLEARSIDE BIOMEDICAL INC. - COMMON STOCK
06 3 2024 11:23:17 提供 NetDania Notify
-
29 2 2024 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Pricing of $15 Million Registered Direct Offering
07 2 2024 07:00:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Reports Significant Progress in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
14 12 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Announces Third Quarter 2023 Financial Results and Provides Corporate Update
13 11 2023 15:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical to Participate in Fireside Chat at the Stifel 2023 Healthcare Conference
08 11 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
07 11 2023 15:20:00 提供 Nasdaq GlobeNewswire
-
02 11 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical Completes Recruitment in ODYSSEY Phase 2b Clinical Trial of CLS-AX in Wet AMD
01 11 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
31 10 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
16 10 2023 06:05:00 提供 Nasdaq GlobeNewswire
-
Clearside Biomedical to Participate in a Panel Discussion at the JonesTrading 2023 Healthcare Summit
03 10 2023 15:35:00 提供 Nasdaq GlobeNewswire